Skip to content

dr. Claes Nele

Borstkliniek
contactgegevens
06/06/2022
Oncologie

Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.

Int J Gynecol Cancer. 2022 Jun 6;32(6):753-760. doi: 10.1136/ijgc-2021-003190.PMID: 35063943 Clinical Trial.dr. Claes Nele
02/01/2021
Oncologie

Effect of lipegfilgrastim administration as prophylaxis of chemotherapy-induced neutropenia on dose modification and incidence of neutropenic events: real-world evidence from a non-interventional study in Belgium and Luxembourg.

Acta Clin Belg. 2021 Feb;76(1):10-15. doi: 10.1080/17843286.2019.1646539. Epub 2019 Aug 9.PMID: 31399016 Clinical Trial.dr. Claes Nele
Oncologie

De Borstkliniek nodigt u uit voor een update van de guidelines: Uitwisselen van ideeën en de aanpak in de verschillende ziekenhuizen.

Brugge2022-10-13dr. Claes Nele
Oncologie

“Regorafenib in patients with pretreated advanced melanoma: a retrospective case series”.

Edinburgh, Scotland2022-10-17dr. Claes Nele